Loss of colour vision in patients at risk of developing diabetes

Abstract

AbstractRecent studies carried out in diabetic patients with no more than moderate maculopathy revealed that over 70% had significant losses of both Yellow/Blue (YB) and Red/Green (RG) colour vision (https://doi.org/10.1111/j.1755-3768.2012.F073.x). The purpose of this study was to investigate whether clinically ‘normal’ subjects, identified as being at ‘risk’ of developing diabetes show significant changes in rod‐ and cone‐mediated rapid flicker sensitivity as well as RG and YB colour vision.Three groups of subjects were recruited; a normal subject group (n = 40), a ‘high‐risk’ group (n = 150) and subjects diagnosed with diabetes (n = 23). The inclusion criteria for ‘high‐risk’ group required 3 or more recognized risk factors for diabetes (e.g., age > 45, HbA1C >5.7, high blood pressure, smoking history, high BMI, family history of diabetes, FPG levels >100 mg/dL). All subjects had full ophthalmic assessment and their RG and YB colour vision, Functional Contrast Sensitivity (FCS), Visual Acuity (VA) and Rod‐ and Cone‐mediated flicker sensitivity were measured using AVOT tests (https://researchcentres.city.ac.uk/applied-vision/avot).Consistent with previous findings, the diabetic group show significant loss of both RG and YB colour vision. Our findings show that these subjects also exhibit higher thresholds for rod and cone mediated vision. In addition, the ‘high‐risk’ group who are clinically classified as ‘normal’, also show significant loss of colour vision and rod and cone sensitivity. The latter group, do not, however, show significant differences in either VA or FCS. These findings suggest that accurate assessment of colour vision and rod‐ and cone‐ mediated rapid flicker sensitivity qualify as important risk factors in prediabetic screening.